Overview of Ear, Nose, and Throat Complaints of Covid 19 Inpatients at the University of Muhammadiyah Malang Hospital for the Period April 2021 to June 2021
DOI:
https://doi.org/10.22219/sm.Vol18.SMUMM1.21604Abstract
Covid-19 is spreading rapidly to other countries, and WHO confirmed it as a pandemic disease in March 2020. The virus enters directly to the surface of the mucosa with a high viral load, so it is clear that complaints in the nose and throat area are found. Covid-19 initially appears mainly in the airway with symptoms can be fever and dyspnea cough which can quickly switch to acute respiratory distress syndrome. RSU Universitas Muhammadiyah Malang has been one of the Covid-19 referral hospitals in East Java since April 2020, and there is no data on the description of nasal ear and throat complaints (ENT) in Covid-19 hospitalization patients at UMM Hospital. Mengetahui overview and overview of nose and throat ear complaints (ENT) experienced by Covid-19 hospitalized patients at UMM Hospital in the period April 2021 to June 2021. Descriptive retrospectively by taking data from the medical records of Covid-19 hospitalization patients of UMM Hospital in the period April to June 2021 with a total sampling method of 161 hospitalized patients with a confirmed diagnosis of Covid-19 with PCR examination during the period of April to June 2021. The study was conducted on 161 medical records with the results of 84 patients were men with 21 patients with severe degrees, 63 patients with moderate degrees, and 77 patients were women with 18 patients with severe degrees and 59 patients with moderate degrees. Mortality rates were obtained in as many as 26 (16%) with varying age ranges; 78 (48%) patients had comorbidities, with Diabetes mellitus as the highest comorbid among as many as 31 (40%) patients. Patients with ENT complaints were obtained among as many as 95 (60%) patients, and 66 (40%) patients were not accompanied by ENT complaints. The three most ENT complaints were colds (rhinitis) in as many as 62 (39%) patients, anosmia hyposmia in as many as 26 (16%) patients, and throat pain in as many as 22 (14%) patients. Most patients were men with moderate degrees, with mortality rates of 16% and 48% of patients accompanied by comorbidities. The most ENT complaints were rhinitis 39%, anosmia-hyposmia 16%, and throat pain in as much as 14% of patients.
Downloads
References
Abraham JP, Plourde BD, Cheng L. Using heat to kill SARSCoV-2. Rev Med Virol. 2020;30(5):e2115. PMID: 32614102. doi:10.1002/rmv.2115
Adivitiya, Kaushik MS, Chakraborty S, Veleri S, Kateriya S. Mucociliary respiratory epithelium integrity in molecular defense and Susceptibility to Pulmonary viral infection. Biology. 2021, 10, 95 doi.org/10/3390/biology10020095
Akerlund A, Bende M. Nasal mucosal temperature and the effect of acute infective rhinitis. Clin Otolaryngol Allied Sci. 1989; 14(6):529-534. PMID: 2612033. doi:10.1111/j.1365-2273.1989.tb00418.x
Baig AM. Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS
Neurosci Ther 2020;26:499–501. https://doi.org/10.1111/cns.13372.
Bende M, Barrow I, Heptonstall J, et al. Changes in human
nasal mucosa during experimental coronavirus common colds.
Acta Otolaryngol. 1989;107(3-4):262-269. PMID: 2538995.
doi:10.3109/00016488909127507
Borah H, Das S, Goswani A. Otorhinolatyngological Manifestations and Its Management in Covid-19 Patients. Indian J Otolaryngol Head Neck Surg. 2021. doi.org/10.1007/s12070-021-02436-9
Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med 2020. https://doi.org/10.7326/M20-1176. [M20-1176, Apr 17. [Epub ahead of print]].
Fidan V. New type of corona virus induced acute otitis media in adult,
Am J Otolaryngol. 2020;41
Foxman EF, Storer JA, Fitzgerald ME, et al. Temperaturedependent innate defense against the common cold virus limitsviral replication at warm temperature in mouse airway cells. ProcNatl Acad Sci U S A. 2015;112(3):827-832. PMID: 25561542.doi:10.1073/pnas.1411030112
Maharaj S, Alvarez MB, Mungul S, Hari K. Otologic dysfunction in patients with COVID-19: A systematic review. Laryngoscope Investigative Otolaryngology, 2020; 5: 1192-1196. doi: 10.1002/lio2.498
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of
hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020. https://doi.org/10.1001/jamaneurol.2020.1127. [Apr 10. [Epub ahead of print]].
Nastiti RD, Artanti KD, Faqih AF. (2020) 'Analysis of Epidemiological Surveillance Activity of the Covid-19 at Surabaya Airport Indonesia on January 2020', National Public Health Journal, Special Issue I: 77-84. doi: 10.21109/kesmas.v15i2.3953
Rockx B, Kuiken T, Herfst S, Bestebroer T, Lamers MM, Oude Munnink BB.
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate type. Science 2020; 368: 1012–5. https://doi.org/10.1126/science.abb7314.
Saniasiaya J, Kulasegarah J. Dissiness and Covid-19. Ear, Nose& Throat. 2020. p 1-2. doi:10.1177/0145561320959573
Sayin I, Yazici ZM, Akgul A. Local nasal response against COVID-19: Debate Regarding the Absence of Nasal Inflammatory Symtoms. Ear, Nose & Throat Journal. 2021. DOI: 10.1177/0145561321992505
Vaira LA, Deiana G, Fois AG et al. Objective evaluation of anosmia and ageusia in Covid-19 patients: single-center experiece on 72 cases. Head Neck 42(6): 1252-1258. https://doi.org/10.1002/hed.26204
WHO. Weekly Operational Update on COVID-19. Issue 64. 2021.
WHO. Coronavirus disease (COVID-19) outbreak situation. WHO. 2021.https://experience.arcgis.com/experience/685d0ace5.
Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with Covid-19 and other coronavirus. Brain Behav Immun Mar 39, 2020. https://doi.org/10.1016/j.bbi.2020.03.031.
Yep TF, Liu Z, Shveda RA, Preston DJ. A predictive model of the temperature-dependent inactivation of coronaviruses. Appl Phys Lett. 2020;117(6):060601. PMID: 32817726. doi:10.1063/5.0020782
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Nimim Putri Zahara, Jauhar Tajudin
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.